Found 0 matching trials
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer PHASE1 RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Show More Location
Multiple Locations
Learn More & Join Trial
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
MOR-1 Expression in Colorectal Cancer and Disease-free Survival Relationship. Five-year Follow-up. N/A Colorectal cancer (CRC) is a global burden and one of the most frequent typ...
Show More Location
Hospital Universitario La Fe
Learn More & Join Trial
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia PHASE1 This phase I trial studies the side effects and best dose of ipilimumab and...
Show More Learn More & Join Trial
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma PHASE2 RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Show More Location
Vanderbilt-Ingram Cancer Center
Learn More & Join Trial
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim N/A RATIONALE: Studying samples of blood from patients treated with sargramosti...
Show More Location
Multiple Locations
Learn More & Join Trial
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma PHASE2 The main purpose of this trial is to investigate the effects of a new class...
Show More Location
Northwestern University
Learn More & Join Trial
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery PHASE1 RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be a...
Show More Location
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Learn More & Join Trial
Effect of Boceprevir on HCV-specific T Cell Responses N/A Analysis of HCV-specific T cell responses in patients treated with boceprev...
Show More Location
Unit of Infectious Diseases and Hepatology
Learn More & Join Trial
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors PHASE1 RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial